Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use
Gadolinium-based contrast agents have expanded the diagnostic usefulness and capability of magnetic resonance imaging. Despite their highly favorable safety profile, these agents have been associated with nephrogenic systemic fibrosis in a small number of patients who have advanced kidney disease. R...
Gespeichert in:
| Veröffentlicht in: | Texas Heart Institute journal 2022-01, Vol.49 (3) |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 3 |
| container_start_page | |
| container_title | Texas Heart Institute journal |
| container_volume | 49 |
| creator | Cheong, Benjamin Y C Wilson, James M Preventza, Ourania A Muthupillai, Raja |
| description | Gadolinium-based contrast agents have expanded the diagnostic usefulness and capability of magnetic resonance imaging. Despite their highly favorable safety profile, these agents have been associated with nephrogenic systemic fibrosis in a small number of patients who have advanced kidney disease. Recently, trace amounts of gadolinium deposition in the brain and other organs have been reported after contrast exposure, even in patients with normal renal function. In this review, we provide a brief overview of recent updates and discuss typical clinical situations related to the use of gadolinium-based contrast agents. |
| doi_str_mv | 10.14503/THIJ-21-7680 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9242635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2669502616</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-41afc6d99c248c981ca761ca05c0ab9fda664e10007ae7ab8c912c040e9322ff3</originalsourceid><addsrcrecordid>eNpVkc9PwjAYhhujEUSPXk2PXqr9sXXMgwkSBQyJ0cC5-eg6rBktrpuG_95NEPXS79Anz_e9eRE6Z_SKRTEV17Px5JFwRhLZpweoy2IuiUwoP0RdmghKuIiSDjoJ4Y1SKjjjx6gjYsl4SmUX6RFkvrDO1ityB8FkeOhdVUKo8GBpXBVu8HydQWUCBpfhgQufpgy48ni2WVsNBX6uTaisdwG_mCWUmXVL_CvF82BO0VEORTBnu9lD84f72XBMpk-jyXAwJVr0k4pEDHItszTVPOrrtM80JLJ5aKwpLNI8Aykjw5oUCZgEFg3DuKYRNangPM9FD91uvet6sTKZNm2QQq1Lu4JyozxY9f_H2Ve19B8q5RGXIm4ElztB6d_bWGplgzZFAc74OiguZRpTLplsULJFdelDKE2-X8Oo-i5GtcUozlRbTMNf_L1tT_80Ib4ABOOK9g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2669502616</pqid></control><display><type>article</type><title>Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Cheong, Benjamin Y C ; Wilson, James M ; Preventza, Ourania A ; Muthupillai, Raja</creator><creatorcontrib>Cheong, Benjamin Y C ; Wilson, James M ; Preventza, Ourania A ; Muthupillai, Raja</creatorcontrib><description>Gadolinium-based contrast agents have expanded the diagnostic usefulness and capability of magnetic resonance imaging. Despite their highly favorable safety profile, these agents have been associated with nephrogenic systemic fibrosis in a small number of patients who have advanced kidney disease. Recently, trace amounts of gadolinium deposition in the brain and other organs have been reported after contrast exposure, even in patients with normal renal function. In this review, we provide a brief overview of recent updates and discuss typical clinical situations related to the use of gadolinium-based contrast agents.</description><identifier>ISSN: 0730-2347</identifier><identifier>EISSN: 1526-6702</identifier><identifier>DOI: 10.14503/THIJ-21-7680</identifier><identifier>PMID: 35612906</identifier><language>eng</language><publisher>United States: Texas Heart® Institute, Houston</publisher><subject>Review</subject><ispartof>Texas Heart Institute journal, 2022-01, Vol.49 (3)</ispartof><rights>2022 by the Texas Heart® Institute, Houston.</rights><rights>2022 by the Texas Heart® Institute, Houston 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-41afc6d99c248c981ca761ca05c0ab9fda664e10007ae7ab8c912c040e9322ff3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242635/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242635/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35612906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheong, Benjamin Y C</creatorcontrib><creatorcontrib>Wilson, James M</creatorcontrib><creatorcontrib>Preventza, Ourania A</creatorcontrib><creatorcontrib>Muthupillai, Raja</creatorcontrib><title>Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use</title><title>Texas Heart Institute journal</title><addtitle>Tex Heart Inst J</addtitle><description>Gadolinium-based contrast agents have expanded the diagnostic usefulness and capability of magnetic resonance imaging. Despite their highly favorable safety profile, these agents have been associated with nephrogenic systemic fibrosis in a small number of patients who have advanced kidney disease. Recently, trace amounts of gadolinium deposition in the brain and other organs have been reported after contrast exposure, even in patients with normal renal function. In this review, we provide a brief overview of recent updates and discuss typical clinical situations related to the use of gadolinium-based contrast agents.</description><subject>Review</subject><issn>0730-2347</issn><issn>1526-6702</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkc9PwjAYhhujEUSPXk2PXqr9sXXMgwkSBQyJ0cC5-eg6rBktrpuG_95NEPXS79Anz_e9eRE6Z_SKRTEV17Px5JFwRhLZpweoy2IuiUwoP0RdmghKuIiSDjoJ4Y1SKjjjx6gjYsl4SmUX6RFkvrDO1ityB8FkeOhdVUKo8GBpXBVu8HydQWUCBpfhgQufpgy48ni2WVsNBX6uTaisdwG_mCWUmXVL_CvF82BO0VEORTBnu9lD84f72XBMpk-jyXAwJVr0k4pEDHItszTVPOrrtM80JLJ5aKwpLNI8Aykjw5oUCZgEFg3DuKYRNangPM9FD91uvet6sTKZNm2QQq1Lu4JyozxY9f_H2Ve19B8q5RGXIm4ElztB6d_bWGplgzZFAc74OiguZRpTLplsULJFdelDKE2-X8Oo-i5GtcUozlRbTMNf_L1tT_80Ib4ABOOK9g</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Cheong, Benjamin Y C</creator><creator>Wilson, James M</creator><creator>Preventza, Ourania A</creator><creator>Muthupillai, Raja</creator><general>Texas Heart® Institute, Houston</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220101</creationdate><title>Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use</title><author>Cheong, Benjamin Y C ; Wilson, James M ; Preventza, Ourania A ; Muthupillai, Raja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-41afc6d99c248c981ca761ca05c0ab9fda664e10007ae7ab8c912c040e9322ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheong, Benjamin Y C</creatorcontrib><creatorcontrib>Wilson, James M</creatorcontrib><creatorcontrib>Preventza, Ourania A</creatorcontrib><creatorcontrib>Muthupillai, Raja</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Texas Heart Institute journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheong, Benjamin Y C</au><au>Wilson, James M</au><au>Preventza, Ourania A</au><au>Muthupillai, Raja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use</atitle><jtitle>Texas Heart Institute journal</jtitle><addtitle>Tex Heart Inst J</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>49</volume><issue>3</issue><issn>0730-2347</issn><eissn>1526-6702</eissn><abstract>Gadolinium-based contrast agents have expanded the diagnostic usefulness and capability of magnetic resonance imaging. Despite their highly favorable safety profile, these agents have been associated with nephrogenic systemic fibrosis in a small number of patients who have advanced kidney disease. Recently, trace amounts of gadolinium deposition in the brain and other organs have been reported after contrast exposure, even in patients with normal renal function. In this review, we provide a brief overview of recent updates and discuss typical clinical situations related to the use of gadolinium-based contrast agents.</abstract><cop>United States</cop><pub>Texas Heart® Institute, Houston</pub><pmid>35612906</pmid><doi>10.14503/THIJ-21-7680</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0730-2347 |
| ispartof | Texas Heart Institute journal, 2022-01, Vol.49 (3) |
| issn | 0730-2347 1526-6702 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9242635 |
| source | PubMed Central; Alma/SFX Local Collection |
| subjects | Review |
| title | Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A34%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gadolinium-Based%20Contrast%20Agents:%20Updates%20and%20Answers%20to%20Typical%20Questions%20Regarding%20Gadolinium%20Use&rft.jtitle=Texas%20Heart%20Institute%20journal&rft.au=Cheong,%20Benjamin%20Y%20C&rft.date=2022-01-01&rft.volume=49&rft.issue=3&rft.issn=0730-2347&rft.eissn=1526-6702&rft_id=info:doi/10.14503/THIJ-21-7680&rft_dat=%3Cproquest_pubme%3E2669502616%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2669502616&rft_id=info:pmid/35612906&rfr_iscdi=true |